In osteosarcoma, the most frequent malignant primary bone tumor in children and young adults, ZDHHC19 was found to be highly expressed, and knockdown of ZDHHC19 led to downregulated expression of Wnt/β-catenin [69] (Figure 3b). This evidence concerns the gene ZDHHC19 and osteosarcoma.